Background Image
Table of Contents Table of Contents
Previous Page  61 / 61
Information
Show Menu
Previous Page 61 / 61
Page Background

ZARTAN 50, 100 mg.

Each tablet contains 50, 100 mg losartan potassium respectively. S3 A41/7.1.3/0287, 0289. NAM NS2 08/7.1.3/0067, 0086. For full prescribing information, refer to the professional information

approved by SAHPRA, 31 August 2019.

ZARTAN CO 50/12,5, 100/25.

Each tablet contains 50, 100 mg losartan potassium and 12,5, 25 mg hydrochlorothiazide respectively. S3 A42/7.1.3/1068, 1069. NAM NS2

12/7.1.3/0070, 0071. For full prescribing information, refer to the professional information approved by SAHPRA, 31 July 2019.

1)

Dahlöf B,

et al.

Cardiovascular morbidity and mortality in losartan intervention for endpoint

reduction in hypertension study (LIFE): a randomised trial against atenolol.

The Lancet

2002;359:995-1003.

2)

Brenner BM,

et al.

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes

and nephropathy.

N Engl J Med

2001;345(12):861-869.

3)

Pitt B,

et al.

Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE).

Lancet

1997;349:747–52.

4)

Database of Medicine Prices (12 March 2021). Department of Health website.

http://www.mpr.gov.za

.

ZNCH730/05/2021.

holds rank

in hypertension

Effective BP lowering with an

ARB at an affordable price.

1,2,3,4

MORE

AFFORDABLE

THAN THE

ORIGINATOR

4

UP TO

32

%

MORE

AFFORDABLE

THAN THE

ORIGINATOR

4

UP TO

43

%

For further product information contact

PHARMA DYNAMICS

P O Box 30958 Tokai Cape Town 7966

Fax

+27 21 701 5898

Email

info@pharmadynamics.co.za

CUSTOMER CARE LINE

0860 PHARMA (742 762) / +27 21 707 7000

www.pharmadynamics.co.za